Genkyotex

Genkyotex is a biopharmaceutical company that develops and commercializes NOX therapies for fibrosis, inflammation and cancer diseases.

Business Model:

Revenue: $908.2k

Employees: 11-50

Rankings

Detailed Genkyotex Information

Genkyotex was acquired by Calliditas Therapeutics.
The acquisition happend on 2020-08-13.
Details of the transaction were not public

Geographic Data

Genkyotex headquarters map

Address: Forum 2 Archamps Technopole 218 Marie Curie Avenue

City: Saint-Julien-en-Genevois

State: auvergne

Zip: 74166

Country: FR

Financial Info

Stage:

post ipo equity

Raised Last:

$5M

Raised Total:

$49M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Genkyotex is a biopharmaceutical company that develops and commercializes NOX therapies for fibrosis, inflammation and cancer diseases.

Contact Phone:

Contact Email:

Genkyotex went public on 4/11/2014 on the PA

Listed Exchange:
PA

IPO Date:
4/11/2014

Ticker Symbol:
Paris:GKTX

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
5/2011 Series C 5 $20.4M Andera Partners
Vesalius Biocapital Partners
MP Healthcare Venture Management
Fondation d&s;Aide aux Entreprises
Eclosion SA
Andera Partners
4/2010 Series C $17.7M Idinvest Partners
Amundi Private Equity Funds
Edmond de Rothschild
8/2019 Debt $1.8M
1/2015 Series D $21M NeoMed Management
VI Partners
BioMedInvest
Edmond de Rothschild Investment Partners
Eclosion2
Vesalius Biocapital Partners
2/2020 Post-IPO Equity $5.4M
5/2008 Series A 1 $4M Societe Generale Asset Management
Societe Generale Asset Management
1/2006 Seed Round 1 $1.6M Eclosion SA
1/2015 Post-IPO Equity $0 VI Partners
Vesalius Biocapital Partners
Neomed Management
Andera Partners
Eclosion SA
BioMedPartners
Edmond de Rothschild Private Equity
Neomed Management
VI Partners
Vesalius Biocapital Partners
Neomed Management
Andera Partners
Eclosion SA
BioMedPartners
Edmond de Rothschild Private Equity
Neomed Management
7/2012 Series C 4 $25.6M Vesalius Biocapital Partners
Andera Partners
MP Healthcare Venture Management
Eclosion SA
Vesalius Biocapital Partners
Andera Partners
MP Healthcare Venture Management
8/2018 Post-IPO Equity $8.7M
5/2009 Series A $1.8M
8/2018 Convertible Note $8.6M
1/2015 Post-IPO Equity 7 $19.7M VI Partners
Vesalius Biocapital Partners
Neomed Management
Andera Partners
Eclosion SA
BioMedPartners
Edmond de Rothschild Private Equity
Neomed Management
VI Partners
Vesalius Biocapital Partners
Neomed Management
Andera Partners
Eclosion SA
BioMedPartners
Edmond de Rothschild Private Equity
Neomed Management
Announced Date Name Price
2/2017 Genticel

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research